Linnaeus Therapeutics

Biotech developing small molecule therapies for cancer, guided by clinical experience

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2018 groups5 employees language linnaeustx.com

Innovation

3 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 103 times.

YearFilings
20201
20211
20223
20233
20243
20253
20261

Social engagement

Social engagement: 971 social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Kairos Ventures.

Investor typeCountShare
Venture capital125%
Accelerator & incubator125%
Other / undisclosed250%

Recent activity

14 May 2026
Recognition
14 May 2026
Recognition
Coming soon